Search

Author/Creator Perez-Moreno, Pablo

1. Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial. (February 2015)

Authors:
de Marinis, Filippo; Vergnenegre, Alain; Passaro, Antonio; Dubos-Arvis, Catherine; Carcereny, Enric; Drozdowskyj, Ana; Zeaiter, Ali; Perez-Moreno, Pablo; Rosell, Rafael
Journal:
Future oncology
Issue:
Volume 11:Number 3(2015)
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer. (August 2016)

Authors:
Mok, Tony; Ladrera, Guia; Srimuninnimit, Vichien; Sriuranpong, Virote; Yu, Chong-Jen; Thongprasert, Sumitra; Sandoval-Tan, Jennifer; Lee, Jin Soo; Fuerte, Fatima; Shames, David S.; Klughammer, Barbara; Truman, Matt; Perez-Moreno, Pablo; Wu, Yi-Long
Journal:
Lung cancer
Issue:
Volume 98(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer. (August 2016)

Authors:
Mok, Tony; Ladrera, Guia; Srimuninnimit, Vichien; Sriuranpong, Virote; Yu, Chong-Jen; Thongprasert, Sumitra; Sandoval-Tan, Jennifer; Lee, Jin Soo; Fuerte, Fatima; Shames, David S.; Klughammer, Barbara; Truman, Matt; Perez-Moreno, Pablo; Wu, Yi-Long
Journal:
Lung cancer
Issue:
Volume 98(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search